We studied serum amylase and its isoenzymes prospectively in 163 conse
cutive asymptomatic patients, 149 men and 14 women, infected with HIV
and attending an HIV out-patient clinic. Six patients were receiving d
ideoxyinosine (DDI), a drug known to cause pancreatitis. No patient, h
owever, had clinical signs suggestive of pancreatitis. Serum total amy
lase was increased in 39 of 163 patients (24%), in 11 of whom (28%), t
his was due to increased pancreatic (P) isoamylase alone, in 17 (42%)
it was due to salivary (S) type alone and in six (17%) it was due to i
ncrease of both P and S fractions. In five patients (13%), macroamylas
e was detected. Pancreatic amylase was elevated in four of the six pat
ients on DDI. The remaining two had macroamylase. Our results show tha
t asymptomatic hyperamylasaemia is a common finding in HIV patients an
d that it appears to be heterogenous, i.e. elevation may be due to inc
rease in P or S, both enzyme fractions or macroamylase. The high incid
ence of macroamylasaemia in HIV patients was an unexpected finding.